-

09:04:14 PM

Latest CODX Stock Market News

CODX - Co-Diagnostics Inc

08/04/21 11:30 AM

Nasdaq : CODX

earnings

Co-Diagnostics, Inc. Announces Second Quarter 2021 Earnings Release Date And Webcast

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its second quarter 2021 results on Thursday, August 12, 2021, after

RHEA-AI

neutral

07/22/21 9:30 AM

Nasdaq : CODX

Co-Diagnostics, Inc. Strengthens Intellectual Property Portfolio with New International CoPrimer™ Patent

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it has added to its suite of intellectual property protection after being

RHEA-AI

neutral

06/18/21 10:30 AM

Nasdaq : CODX

Co-Diagnostics, Inc Receives CE Marking for Direct Saliva SARS-CoV-2 Test

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that its Logix Smart™ SARS-CoV-2 DS (Direct Saliva) has obtained regulatory

RHEA-AI

neutral

06/15/21 9:30 AM

Nasdaq : CODX

conferences

Co-Diagnostics, Inc. to Present at Upcoming Technology and Health Research Conferences

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be presenting virtually this week at the 28 th

RHEA-AI

neutral

05/04/21 9:30 AM

Nasdaq : CODX

earnings

Co-Diagnostics, Inc. Announces First-Quarter 2021 Earnings Release Date and Webcast

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first-quarter 2021 results on Thursday, May 13, 2021, after the

RHEA-AI

neutral

04/29/21 9:30 AM

Nasdaq : CODX

Co-Diagnostics, Inc. and Partner CRL to Discuss Saliva Testing and Future Applications of PCR in 360Dx Webinar

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that it will be accompanying Dr. Heather Fehling, Chief Scientific Officer at

RHEA-AI

neutral

04/28/21 9:30 AM

Nasdaq : CODX

covid-19

Co-Diagnostics, Inc. JV CoSara Diagnostics Recognized for Work Combating COVID-19 Surge in India

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that its Indian manufacturing facility, CoSara Diagnostics Pvt. Ltd.

RHEA-AI

neutral

04/20/21 9:30 AM

Nasdaq : CODX

Co-Diagnostics, Inc. Test Performance Demonstrated by Australian Researchers in Peer-Reviewed Publication

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that its Logix Smart™ COVID-19 Test Kit was used by Australian researchers to demonstrate

RHEA-AI

neutral

03/31/21 9:30 AM

Nasdaq : CODX

Co-Diagnostics, Inc. CEO Discusses Company Strategy for the Future with Yahoo! Finance

The CEO of Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, appeared yesterday on Yahoo! Finance to comment on the Company's recently-released FY2020 earnings

RHEA-AI

very positive

03/25/21 4:01 PM

Nasdaq : CODX

earnings

Co-Diagnostics Reports Fourth-Quarter and Full-Year 2020 Financial Results

Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today financial results for the fourth quarter and full year ended December 31,

RHEA-AI

positive

CODX Data

industrySurgical and Medical Instrument Manufacturing
websitecodiagnostics.com
ceoDwight Egan
security nameCo-Diagnostics Inc
issue typecs
sectorManufacturing
sic code3841
employees37
tagsHealth Technology,Biotechnology,Manufacturing,Surgical and Medical Instrument Manufacturing
address4049 S Highland Dr
address2
stateUtah
citySalt Lake City
zip84124-1664
countryUS
phone18012789769

CODX Description:

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.